Skye Bioscience, Inc. Payments to Acquire Short-term Investments
Skye Bioscience, Inc. (SKYE) reported Payments to Acquire Short-term Investments of $19.85 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2026-03-10
- Skye Bioscience, Inc. payments to acquire short-term investments for the quarter ending 2025-12-31 was $2.98M.
- Skye Bioscience, Inc. payments to acquire short-term investments for the quarter ending 2025-09-30 was -$7.88M.
- Skye Bioscience, Inc. payments to acquire short-term investments for the quarter ending 2025-06-30 was $11.94M.
- Skye Bioscience, Inc. payments to acquire short-term investments for the quarter ending 2025-03-31 was $12.80M.
- Skye Bioscience, Inc. payments to acquire short-term investments for fiscal 2025 was $19.85M.
- Skye Bioscience, Inc. payments to acquire short-term investments for fiscal 2024 was $0.00.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$4.89M derived: sum of 2 quarters · filed 2026-03-10 | $7.05M derived: sum of 3 quarters · filed 2026-03-10 | $19.85M 10-K · filed 2026-03-10 |
| 2025-09-30 | -$7.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $4.07M derived: sum of 2 quarters · filed 2025-11-10 | $16.87M 10-Q · filed 2025-11-10 | $16.87M derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-06-30 | $11.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $24.75M 10-Q · filed 2025-08-07 | $24.75M derived: sum of 3 quarters · filed 2026-03-10 | $24.75M derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-03-31 | $12.80M 10-Q · filed 2025-05-08 | $12.80M derived: sum of 2 quarters · filed 2026-03-10 | $12.80M derived: sum of 3 quarters · filed 2026-03-10 | $12.80M derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $0.00 derived: sum of 3 quarters · filed 2026-03-10 | $0.00 10-K · filed 2026-03-10 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |